This study used GATK and seqr in Terra to identify variants likely to cause neurodevelopmental disorders, based on exome data from family trios.
This pediatric oncology study used Terra to identify germline variants contributing to Ewing sarcoma pathogenesis in 1,147 individuals with pediatric sarcoma diagnoses.
This chronic lymphocytic leukemia (CLL) study used Terra to process and analyze WES, WGS, RNA-seq, RRBS, and targeted NOTCH1 sequencing data.
This population genetics study used Terra to identify mitochondrial variants in 56K+ whole genomes from the gnomAD database using a scalable GATK workflow.
This prostate cancer study used Terra to process exome sequencing and single-cell RNAseq data with automated workflows.
This spotlight on the paper describing the Telomere-to-Telomere genome reference highlights how the variant calling part of the work was implemented in Terra.
This spotlight on a peer-reviewed paper about the 2021 Delta variant outbreak in Provincetown, MA highlights how the viral genomics part of the work was implemented in Terra.
Terra is developed by the Broad Institute of MIT and Harvard in collaboration with Microsoft and Verily.
